MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease.
about
MicroRNAs in atherosclerosis and lipoprotein metabolismAssociation of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesotheliomaWhole transcriptome analysis: what are we still missing?A thermo-sensitive NIPA-based co-polymer and monosize polycationic nanoparticle for non-viral gene transfer to smooth muscle cells.MicroRNAs in cardiometabolic disease.MicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1.Role for miR-204 in human pulmonary arterial hypertensionThe miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells.Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotypeCilostazol Inhibits Vascular Smooth Muscle Cell Proliferation and Reactive Oxygen Species Production through Activation of AMP-activated Protein Kinase Induced by Heme Oxygenase-1.Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease.MicroRNAs in vascular diseaseTissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysmMicroRNAs in vascular biology and vascular diseasemiR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40Downregulation of microRNA‑34b is responsible for the elevation of blood pressure in spontaneously hypertensive rats.miRNAs: roles and clinical applications in vascular disease.MicroRNA regulation of lipid metabolism.Frontiers in preclinical safety biomarkers: microRNAs and messenger RNAs.Gene therapy for vein graft failure.microRNAs as Developmental Regulators.The multifactorial nature of microRNAs in vascular remodelling.MiR-145-5p regulates hypoxia-induced inflammatory response and apoptosis in cardiomyocytes by targeting CD40.MicroRNAs-control of essential genes: Implications for pulmonary vascular disease.MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patientsDownregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseasesMicroRNA Regulation of Smooth Muscle Phenotype.MicroRNA-141 inhibits vascular smooth muscle cell proliferation through targeting PAPP-A.General principles and methods for routine automated microRNA in situ hybridization and double labeling with immunohistochemistry.Circulating miR-145 is associated with plasma high-sensitivity C-reactive protein in acute ischemic stroke patients.microRNA-612 is downregulated by platelet-derived growth factor-BB treatment and has inhibitory effects on vascular smooth muscle cell proliferation and migration via directly targeting AKT2.MicroRNA-206 regulates vascular smooth muscle cell phenotypic switch and vascular neointimal formation.Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
P2860
Q27692124-4A57FC1B-D753-46C5-9266-E63321DB5642Q28387413-CC863C86-F265-4363-9528-CADB964ABF15Q33783513-CE56D7DB-C72F-430A-A89A-F9C6B4646A3CQ33817620-37486898-E12B-453D-AAD5-99D1BD5E1646Q34175509-E689A77C-AE76-488B-AF20-C7D8458EA392Q34420579-BF84A0C9-6E55-4783-AAC4-26843503FB5FQ34681312-F43450BB-12F3-4A72-B1EB-DCB6788E9285Q35150176-BA2530D6-705A-4F85-AC7C-0A31E0B6C084Q35172003-677C0016-9623-45D1-AB20-276FB6E4927DQ35270041-3BE314E5-6F9E-4102-965B-D03752812EF1Q35566567-2C672FD8-72A8-4E40-A09F-26FBB3324732Q35895428-CAD2B4F1-A529-4DA4-8185-F819063A982BQ36522609-71347D61-2152-4799-9A65-A057825513C4Q36766363-B62F807D-1015-4FF3-AD37-D289BA09AB34Q37093868-7711EFB2-7D3A-467C-A0F0-B6A7414E4F88Q37722155-A737F9CA-0A5E-43D5-A542-A8A166695EFCQ37822463-1949EBE4-E618-4616-98E3-54516AB32D2AQ38011295-F22C8790-5D74-45D0-AC77-E6C8087ED99DQ38015647-0ACAB7A3-EF76-4607-A320-07F1BA1FC889Q38081951-6A2749CE-D442-47A1-9838-AEC4AA711F92Q38541779-3BA936EE-A04E-422F-BE01-80E6C6E2094AQ38749173-912BFA6C-65F1-43E2-95C6-B1F7B8295DA7Q38915516-C7AEB3D9-808C-4278-BE28-E152338D2094Q39385085-4171165C-805B-4A46-8307-89DCD8E24FFAQ41412889-84AD3C50-90EB-4879-B3DA-AA2CC36646AEQ41562520-834FE6DA-01C3-479F-A2A3-8B6CF5360DB2Q42008733-42EE186A-3B75-479D-9500-2E71E25D88EAQ42936326-F3D4D045-123C-4874-8DE1-A09AF232A482Q43087774-224D1D27-85DF-4359-8005-2A76AAAA7A14Q45817658-32437232-222D-48F4-A8A8-BE71B7301B22Q48117615-BC4362FD-D5B0-4024-8A0F-7E0B54C8968CQ49166713-85819A90-48BB-4F50-9A59-6A0129BA0ABEQ51091066-9F17029F-B0C3-46D9-9E32-DA4E802DBF36Q54151379-9A6D39B5-DEEA-46C2-80F1-668776A40CBD
P2860
MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MicroRNA-145 in vascular smoot ...... c target for vascular disease.
@ast
MicroRNA-145 in vascular smoot ...... c target for vascular disease.
@en
type
label
MicroRNA-145 in vascular smoot ...... c target for vascular disease.
@ast
MicroRNA-145 in vascular smoot ...... c target for vascular disease.
@en
prefLabel
MicroRNA-145 in vascular smoot ...... c target for vascular disease.
@ast
MicroRNA-145 in vascular smoot ...... c target for vascular disease.
@en
P2860
P356
P1433
P1476
MicroRNA-145 in vascular smoot ...... c target for vascular disease.
@en
P2093
Chunxiang Zhang
P2860
P304
P356
10.4161/CC.8.21.9837
P577
2009-11-17T00:00:00Z